Supplementary Table S5. Individual Patient Data Meta-Analysis - Randomized Trials from FDA Approval: Gemtuzumab Ozogamicin for the Treatment of Adults with Newly Diagnosed CD33-Positive Acute Myeloid Leukemia

Emily Y. Jen,Chia-Wen Ko,Jee Eun Lee, Pedro L. Del Valle, Antonina Aydanian, Charles Jewell,Kelly J. Norsworthy,Donna Przepiorka,Lei Nie,Jiang Liu, Christopher M. Sheth,Marjorie Shapiro,Ann T. Farrell,Richard Pazdur

crossref（2023）

引用 0|浏览3

暂无评分

摘要

Supplemental Table 5 describes the 5 randomized trials of GO plus chemotherapy reviewed as part of the safety assessment of GO in combination with chemotherapy.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要